Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00241007 · ClinicalTrials.gov registry record · Phase 3
A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 836
- Enrollment target
NCT00241007 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 836 participants.
The verdict
NCT00241007, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 836 participants
- Enrollment target
Study Summary
SAFETY EXTENSION STUDY TO THE CORE STUDY CVAH631C2301
Interventions
- DRUG VALSARTAN, VALSARTAN+HYDROCHLOROTHIAZIDE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 836 participants |
| Start Date | 2003-12 |
| Est. Completion | 2005-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00241007
The ClinicalTrials.gov registry entry for NCT00241007 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 836 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VALSARTAN, VALSARTAN+HYDROCHLOROTHIAZIDE is the first listed.
NCT00241007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00241007 about?
NCT00241007 is a clinical study titled "A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension". SAFETY EXTENSION STUDY TO THE CORE STUDY CVAH631C2301
What is the current status of trial NCT00241007?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 836 participants. The study started on 2003-12. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00241007?
The interventions under investigation include: VALSARTAN, VALSARTAN+HYDROCHLOROTHIAZIDE (DRUG).
Who is sponsoring clinical trial NCT00241007?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.